This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2019 Sep 5;381(10):945-955.

doi: 10.1056/NEJMcp1810479.

Immune Thrombocytopenia

Nichola Cooper¹, Waleed Ghanima¹

Affiliations

Affiliation

¹ From the Department of Medicine, Hammersmith Hospital, Imperial College, London (N.C.); and the Departments of Medicine, Hematology-Oncology, and Research, Østfold Hospital Trust, Kalnes, and the Department of Hematology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo (W.G.) - both in Norway.

PMID: 31483965
DOI: 10.1056/NEJMcp1810479

Review

Immune Thrombocytopenia

Nichola Cooper et al. N Engl J Med. 2019.

. 2019 Sep 5;381(10):945-955.

doi: 10.1056/NEJMcp1810479.

Authors

Nichola Cooper¹, Waleed Ghanima¹

Affiliation

¹ From the Department of Medicine, Hammersmith Hospital, Imperial College, London (N.C.); and the Departments of Medicine, Hematology-Oncology, and Research, Østfold Hospital Trust, Kalnes, and the Department of Hematology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo (W.G.) - both in Norway.

PMID: 31483965
DOI: 10.1056/NEJMcp1810479

No abstract available

PubMed Disclaimer

Comment in

Immune Thrombocytopenia.
Nohria V, Macie AC. Nohria V, et al. N Engl J Med. 2020 Mar 12;382(11):1077. doi: 10.1056/NEJMc1913324. N Engl J Med. 2020. PMID: 32160680 No abstract available.

Similar articles

Immune thrombocytopenic purpura.
Cines DB, Blanchette VS. Cines DB, et al. N Engl J Med. 2002 Mar 28;346(13):995-1008. doi: 10.1056/NEJMra010501. N Engl J Med. 2002. PMID: 11919310 Review. No abstract available.
Diagnosis and management of primary immune thrombocytopenia in adults.
Ejaz A, Radia D. Ejaz A, et al. Br J Hosp Med (Lond). 2019 Apr 2;80(4):C54-C57. doi: 10.12968/hmed.2019.80.4.C54. Br J Hosp Med (Lond). 2019. PMID: 30951423 Review. No abstract available.
Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy.
Mitsuhashi K, Ishiyama M, Imai Y, Shiseki M, Mori N, Teramura M, Seshimo A, Motoji T. Mitsuhashi K, et al. Br J Haematol. 2012 Sep;158(6):798-800. doi: 10.1111/j.1365-2141.2012.09220.x. Epub 2012 Jul 3. Br J Haematol. 2012. PMID: 22758388 No abstract available.
Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management.
Stasi R, Evangelista ML, Stipa E, Buccisano F, Venditti A, Amadori S. Stasi R, et al. Thromb Haemost. 2008 Jan;99(1):4-13. doi: 10.1160/TH07-08-0513. Thromb Haemost. 2008. PMID: 18217129 Review.
Immune thrombocytopenic purpura.
Marwaha RK, Aggarwal P, Trehan A. Marwaha RK, et al. Indian Pediatr. 1996 Dec;33(12):1019-26. Indian Pediatr. 1996. PMID: 9141802 No abstract available.

See all similar articles

Cited by

A Review of Romiplostim Mechanism of Action and Clinical Applicability.
Bussel JB, Soff G, Balduzzi A, Cooper N, Lawrence T, Semple JW. Bussel JB, et al. Drug Des Devel Ther. 2021 May 26;15:2243-2268. doi: 10.2147/DDDT.S299591. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34079225 Free PMC article. Review.
The Efficacy of High-Dose Dexamethasone vs. Other Treatments for Newly Diagnosed Immune Thrombocytopenia: A Meta-Analysis.
Xiao Q, Lin B, Wang H, Zhan W, Chen P. Xiao Q, et al. Front Med (Lausanne). 2021 May 25;8:656792. doi: 10.3389/fmed.2021.656792. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34113634 Free PMC article.
Thrombopoietin-receptor agonists for adult patients with immune thrombocytopenia: a narrative review and an approach for managing patients fasting intermittently.
Yassin MA, Al-Rasheed M, Al-Khaboori M, Marashi M, Osman H, Wali Y, Al Kindi S, Alsayegh F, Provan D. Yassin MA, et al. Front Cardiovasc Med. 2023 Dec 14;10:1260487. doi: 10.3389/fcvm.2023.1260487. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 38162126 Free PMC article. Review.
Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia.
Ahn SM, Choi EJ, Oh JS, Kim YG, Lee CK, Yoo B, Hong S. Ahn SM, et al. Arthritis Res Ther. 2022 Sep 6;24(1):213. doi: 10.1186/s13075-022-02901-y. Arthritis Res Ther. 2022. PMID: 36068638 Free PMC article.
Fostamatinib is an effective second-line therapy in patients with immune thrombocytopenia.
Boccia R, Cooper N, Ghanima W, Boxer MA, Hill QA, Sholzberg M, Tarantino MD, Todd LK, Tong S, Bussel JB; FIT Clinical Trial Investigators. Boccia R, et al. Br J Haematol. 2020 Sep;190(6):933-938. doi: 10.1111/bjh.16959. Epub 2020 Jul 23. Br J Haematol. 2020. PMID: 33439486 Free PMC article. Clinical Trial.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information